Angioplasty and stents treat renal arteries:
This article was originally published in Clinica
Executive Summary
Endovascular treatments are as effective as bypass for renovascular hypertension but can be performed at a lower cost, US researchers report in the August edition of Radiology. In a retrospective analysis of 130 patients, researchers at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, found that stenting had the highest success rate at 98%, while angioplasty and bypass both exceeded 90%. However, bypassing cost $15,393 versus $1,402 for angioplasty and $2,573 for stenting. Complication rates were 13%, 16% and 38% for angioplasty, stenting and bypass respectively.
You may also be interested in...
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that of rivals Medicenna were presented at the AACR, suggesting there’s life in the modality yet.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.